310 related articles for article (PubMed ID: 38441807)
1. Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options.
Bindoli S; Baggio C; Doria A; Sfriso P
Drugs; 2024 Mar; 84(3):257-274. PubMed ID: 38441807
[TBL] [Abstract][Full Text] [Related]
2. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
Efthimiou P; Kontzias A; Hur P; Rodha K; Ramakrishna GS; Nakasato P
Semin Arthritis Rheum; 2021 Aug; 51(4):858-874. PubMed ID: 34175791
[TBL] [Abstract][Full Text] [Related]
3. Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.
Colafrancesco S; Manara M; Bortoluzzi A; Serban T; Bianchi G; Cantarini L; Ciccia F; Dagna L; Govoni M; Montecucco C; Priori R; Ravelli A; Sfriso P; Sinigaglia L;
Arthritis Res Ther; 2019 Dec; 21(1):275. PubMed ID: 31829244
[TBL] [Abstract][Full Text] [Related]
4. Adult-onset Still's disease: Advances in the treatment.
Castañeda S; Blanco R; González-Gay MA
Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796
[TBL] [Abstract][Full Text] [Related]
5. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
[TBL] [Abstract][Full Text] [Related]
6. Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.
Sfriso P; Bindoli S; Galozzi P
Drugs; 2018 Aug; 78(12):1187-1195. PubMed ID: 30069732
[TBL] [Abstract][Full Text] [Related]
7. Current treatment options and safety considerations when treating adult-onset Still's disease.
Cavalli G; Farina N; Campochiaro C; Baldissera E; Dagna L
Expert Opin Drug Saf; 2020 Dec; 19(12):1549-1558. PubMed ID: 33078630
[TBL] [Abstract][Full Text] [Related]
8. Adult onset Still's disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review).
Junge G; Mason J; Feist E
Semin Arthritis Rheum; 2017 Oct; 47(2):295-302. PubMed ID: 28757235
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review.
Cota-Arce JM; Cota J; De León-Nava MA; Hernández-Cáceres A; Moncayo-Salazar LI; Valle-Alvarado F; Cordero-Moreno VL; Bonfil-Solis KL; Bichara-Figueroa JE; Hernández-Hernández J; Villela L
Semin Arthritis Rheum; 2021 Dec; 51(6):1282-1290. PubMed ID: 34493394
[TBL] [Abstract][Full Text] [Related]
10. Adult-onset Still's disease.
Gerfaud-Valentin M; Jamilloux Y; Iwaz J; Sève P
Autoimmun Rev; 2014 Jul; 13(7):708-22. PubMed ID: 24657513
[TBL] [Abstract][Full Text] [Related]
11. Application of systems biology-based in silico tools to optimize treatment strategy identification in Still's disease.
Segú-Vergés C; Coma M; Kessel C; Smeets S; Foell D; Aldea A
Arthritis Res Ther; 2021 Apr; 23(1):126. PubMed ID: 33892792
[TBL] [Abstract][Full Text] [Related]
12. Anakinra in children and adults with Still's disease.
Vastert SJ; Jamilloux Y; Quartier P; Ohlman S; Osterling Koskinen L; Kullenberg T; Franck-Larsson K; Fautrel B; de Benedetti F
Rheumatology (Oxford); 2019 Nov; 58(Suppl 6):vi9-vi22. PubMed ID: 31769856
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive review on adult onset Still's disease.
Giacomelli R; Ruscitti P; Shoenfeld Y
J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and management of adult-onset Still's disease.
Efthimiou P; Georgy S
Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
[TBL] [Abstract][Full Text] [Related]
15. Biological treatment in adult-onset Still's disease.
Pouchot J; Arlet JB
Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):477-87. PubMed ID: 23040362
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of abatacept in a refractory case of adult-onset Still's disease.
Quartuccio L; Maset M; De Vita S
Clin Exp Rheumatol; 2010; 28(2):265-7. PubMed ID: 20483052
[TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory adult onset Still's disease with tocilizumab-a single centre experience and literature review.
Reihl Crnogaj M; Čubelić D; Babić A; Mayer M; Anić B
Rheumatol Int; 2020 Aug; 40(8):1317-1325. PubMed ID: 32506202
[TBL] [Abstract][Full Text] [Related]
18. Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment.
Macovei LA; Burlui A; Bratoiu I; Rezus C; Cardoneanu A; Richter P; Szalontay A; Rezus E
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361602
[TBL] [Abstract][Full Text] [Related]
19. Diagnosing and Treating Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease as Part of the Still's Disease Continuum.
Kontzias A; Petryna O; Nakasato P; Efthimiou P
Mediterr J Rheumatol; 2024 Mar; 35(Suppl 1):45-57. PubMed ID: 38756937
[TBL] [Abstract][Full Text] [Related]
20. Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options.
Kadavath S; Efthimiou P
Ann Med; 2015 Feb; 47(1):6-14. PubMed ID: 25613167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
